News - tafamidis

Filter

Current filters:

tafamidis

Popular Filters

FDA advisory panel gives mixed views on Pfizer's tafamidis

25-05-2012

The US Food and Drug Administration's peripheral and Central Nervous System Drugs Advisory Committee…

North AmericaPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

FDA expands Levemir use to young children; negative on tafamidis

23-05-2012

Denmark-based global insulin giant Novo Nordisk (NOV: N) says that the US Food and Drug Administration…

DiabetesLevemirNorth AmericaNovo NordiskPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

FDA now accepts Pfizer’s tafamidis NDA

16-02-2012

Having around a year ago issued a refuse to file letter (The Pharma Letter April 5, 2011), the US Food…

North AmericaPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe

18-11-2011

Following a positive opinion from an advisory committee in the summer (The Pharma Letter July 23), the…

EuropePfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Back to top